ArticleFuture science OA2022
Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy.
Giuseppe Di Lorenzo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it